On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not ...
There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and ...
This page features ASTHO’s legal mapping work to plot the legal landscape for public health priorities, beginning with policies intended to prevent overdose.
This ASTHOReport highlights the public health importance of three harm reduction policies and practices to reduce overdoses: facilitating community distribution of naloxone, facilitating community ...
A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.
On this episode of Public Health Review, we speak with representatives from public health, public safety, and community harm reduction programs to discuss their perspectives, experiences, and the ...
ASTHO Legislative Prospectus | Previewing 2024 state legislative actions on opioid overdose prevention.
Hearing the Hill astho, association of state and territorial health officials, opioid crisis, covid-19 funds, public health, public health data and workforce, american rescue plan, promoting health, ...
ASTHO conducted focus groups to examine overdose-related issues and identify potential engagement opportunities for public health and public safety around overdose prevention. This brief outlines key ...
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...